UPLIZNA (Inebilizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** INEBILIZUMAB

**Strength:** 10 mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Horizon Therapeutics USA, Inc.

**Marketing category:** BLA (BLA761142)

**Pharmacologic class:** CD19-directed Antibody Interactions [MoA], CD19-directed Cytolytic Antibody [EPC]